Non-invasive prenatal testing (NIPT) is a genomic technology used to predict the chance of
a foetus having a genetic condition. Despite the immediacy of this technology's integration
into clinical practice, there is a dearth of evidence outlining how both patients and
professionals experience NIPT on the ground. In this article, we draw upon our collective
empirical research—specifically on earlier screening technologies (BKR), Down syndrome
screening (GT), genetic screening/testing (JL) and NIPT (HS)—to outline the most pressing …